Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julien Hogan

Showing results (61-70 of 123) with videos related to

Pageof 13
Sort By:
Kidney International Reports|March 20, 2023
Predicting Kidney Transplant Recipient Cohorts' 30-Day Rehospitalization Using Clinical Notes and Electronic Health Care Record DataMichael Arenson, Julien Hogan, Liyan Xu, et al.
Pediatric Nephrology (Berlin, Germany)|May 27, 2019
Renal allograft loss due to renal vascular thrombosis in the US pediatric renal transplantationChia-Shi Wang, Larry A Greenbaum, Rachel E Patzer, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 11, 2020
CMV high-risk status and posttransplant outcomes in kidney transplant recipients treated with belataceptGeeta Karadkhele, Julien Hogan, Wairimu Magua, et al.
Pediatric Nephrology (Berlin, Germany)|October 29, 2020
A global antiB cell strategy combining obinutuzumab and daratumumab in severe pediatric nephrotic syndromeClaire Dossier, Benjamin Prim, Christelle Moreau, et al.
Pediatric Nephrology (Berlin, Germany)|June 27, 2022
Benefits of BNP/NT-proBNP serum level evaluation for dry weight adjustment in pediatric hemodialysis patientsAntoine Mouche, Cyrielle Parmentier, Fatma Fendri, et al.
Pediatric Nephrology (Berlin, Germany)|December 16, 2018
Five-year outcome of children with idiopathic nephrotic syndrome: the NEPHROVIR population-based cohort studyClaire Dossier, Jean-Daniel Delbet, Olivia Boyer, et al.
Thrombosis and Haemostasis|October 13, 2018
ADAMTS13 Gene Mutations Influence ADAMTS13 Conformation and Disease Age-Onset in the French Cohort of Upshaw-Schulman SyndromeBérangère S Joly, Pierre Boisseau, Elien Roose, et al.
Frontiers in Pediatrics|October 2, 2024
Efficacy and safety of lumasiran for infants and young children with primary hyperoxaluria type 1: 30-month analysis of the phase 3 ILLUMINATE-B trialYaacov Frishberg, Wesley Hayes, Hadas Shasha-Lavsky, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 12, 2018
APOL1 risk genotype in European steroid-resistant nephrotic syndrome and/or focal segmental glomerulosclerosis patients of different African ancestriesOlivier Gribouval, Olivia Boyer, Bertrand Knebelmann, et al.
Transplantation|April 9, 2025
Donor-derived Cell-free DNA as a Noninvasive Biomarker of Kidney Allograft Rejection in Pediatric Kidney TransplantationJulien Hogan, Roshan George, Carissa Hayes, et al.
Pageof 13

Showing results (61-70 of 123) with videos related to

Sort By:
Pageof 13
Kidney International Reports|March 20, 2023
Predicting Kidney Transplant Recipient Cohorts' 30-Day Rehospitalization Using Clinical Notes and Electronic Health Care Record DataMichael Arenson, Julien Hogan, Liyan Xu, et al.
Pediatric Nephrology (Berlin, Germany)|May 27, 2019
Renal allograft loss due to renal vascular thrombosis in the US pediatric renal transplantationChia-Shi Wang, Larry A Greenbaum, Rachel E Patzer, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 11, 2020
CMV high-risk status and posttransplant outcomes in kidney transplant recipients treated with belataceptGeeta Karadkhele, Julien Hogan, Wairimu Magua, et al.
Pediatric Nephrology (Berlin, Germany)|October 29, 2020
A global antiB cell strategy combining obinutuzumab and daratumumab in severe pediatric nephrotic syndromeClaire Dossier, Benjamin Prim, Christelle Moreau, et al.
Pediatric Nephrology (Berlin, Germany)|June 27, 2022
Benefits of BNP/NT-proBNP serum level evaluation for dry weight adjustment in pediatric hemodialysis patientsAntoine Mouche, Cyrielle Parmentier, Fatma Fendri, et al.
Pediatric Nephrology (Berlin, Germany)|December 16, 2018
Five-year outcome of children with idiopathic nephrotic syndrome: the NEPHROVIR population-based cohort studyClaire Dossier, Jean-Daniel Delbet, Olivia Boyer, et al.
Thrombosis and Haemostasis|October 13, 2018
ADAMTS13 Gene Mutations Influence ADAMTS13 Conformation and Disease Age-Onset in the French Cohort of Upshaw-Schulman SyndromeBérangère S Joly, Pierre Boisseau, Elien Roose, et al.
Frontiers in Pediatrics|October 2, 2024
Efficacy and safety of lumasiran for infants and young children with primary hyperoxaluria type 1: 30-month analysis of the phase 3 ILLUMINATE-B trialYaacov Frishberg, Wesley Hayes, Hadas Shasha-Lavsky, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 12, 2018
APOL1 risk genotype in European steroid-resistant nephrotic syndrome and/or focal segmental glomerulosclerosis patients of different African ancestriesOlivier Gribouval, Olivia Boyer, Bertrand Knebelmann, et al.
Transplantation|April 9, 2025
Donor-derived Cell-free DNA as a Noninvasive Biomarker of Kidney Allograft Rejection in Pediatric Kidney TransplantationJulien Hogan, Roshan George, Carissa Hayes, et al.
Pageof 13